Boston Scientific Corporation clinical trials
The registry lists 612 studies whose lead sponsor is Boston Scientific Corporation or one of 15 companies grouped under it. 43 are recruiting or about to start. Per ClinicalTrials.gov, last updated Nov 18, 2026.
Our grouping of 16 registry names, not the registry’s. See them and correct one ↓
- 612studies on the registry
- 43open to participants now
- 2phase 3 studies under way
- 18reach primary completion within a year
Get an email when these change. Save the Boston Scientific Corporation studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your alerts, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your alerts. Stop any time.
What it is testing
The drugs Boston Scientific Corporation’s studies test, most studies first; none is open now — 10 drugs with a page of their own. Each count opens the studies in search.
Studies, none open
- Aspirin2 in phase 30 open · 3
- Paclitaxel1 in phase 30 open · 3
- Tissue Plasminogen Activator1 in phase 30 open · 3
- 0 open · 2
- thienopyridine2 in phase 30 open · 2
- 0 open · 1
- 0 open · 1
- 0 open · 1
- 0 open · 1
- 0 open · 1
Coming up
18 of Boston Scientific Corporation’s studies under way reach primary completion within a year. The dates are the sponsor’s own estimates, which often move.
Phase 3 Other phases
- 1NNov ’26’26
- 1DDec
- 3JJan ’27’27
- 2FFeb
- MMar
- 2AApr
- MMay
- 3JJun
- 1JJul
- 2AAug
- 1SSep
- 1OOct
- 1NNov
The 12 nearest
- Nov 2026Aquarius Pilot Study to Evaluate the New Axonics Trial SystemNCT07335484
- Dec 2026F15 Recharge Free Axonics SNM System Clinical StudyNCT06186765
- Jan 2027PMCF Study of the Axonics SNM System Model 5101 (R20) for the Indication of OABNCT06789406
- Jan 2027A Global Study Comparing Pulsed Field Ablation With Electrographic Flow Mapping Versus Posterior Wall Ablation for Persistent Atrial FibrillationNCT07187115
- Jan 2027A Feasibility Study to Evaluate the Safety of the TheraSphere Glioblastoma (GBM) Device in Patients With Recurrent GBMNCT05303467
Show 7 moreShow fewer
- Feb 2027Feasibility Study of the FARAFLEX Mapping and PFA SystemNCT06510556
- Feb 2027FARAPULSE Workflow Assessment RegistryNCT06656884
- Apr 2027Repeat Ablation of Persistent Atrial Fibrillation, Including Mitral Isthmus Catheter Ablation, With the FARAPULSE Pulsed Field Ablation SystemNCT06735534
- Apr 2027A Registry on the FARAVIEW Technology of the OPAL HDx Mapping System When Used With the FARAWAVE NAV Ablation Catheter in the Treatment of Atrial FibrillationNCT06808217
- Jun 2027TheraSphere With Durvalumab and Tremelimumab for HCCdurvalumab, tremelimumab · NCT05063565
- Jun 2027A Study on the Acquisition of 2D ICE Images With the CHORUS IDx System in Subjects Undergoing an Ablation ProcedureNCT07353710
- Jun 2027TheraSphere Japan Pre-Market StudyNCT07377487
Add all 18 to your calendar (.ics) → With an account.
What changed recently
From the registry's own updates since Oct 19, 2026.
Started recruiting1
- Combined CM and STN Stimulation for Motor EpilepsyOct 30, 2026NCT07458217
Results posted3
- Ultrasound-facilitated, Catheter-directed, Thrombolysis in Intermediate-high Risk Pulmonary EmbolismNov 16, 2026NCT04790370
- Clinical Study Of a Micro-Implantable Pulse Generator For The Treatment of Peripheral Neuropathic PainNov 13, 2026NCT05287373
- Spinal Cord Stimulation in the Treatment of Chronic, Intractable Pain Using the Nalu™ Neurostimulation SystemNov 4, 2026NCT04503109
All 612 at a glance
Where each study is in its life, its phase and its countries. Each count opens them in search.
Over the years
- 07
- 08
- 09
- 10
- 11
- 3812
- 13
- 14
- 15
- 16
- 17
- 18
- 19
- 20
- 21
- 22
- 23
- 24
- 25
- 2226
By the year each study started; 107 started before 2007. 2026 so far in the lighter column.
Registry sponsor names on this page
Our grouping. This page groups the registry's lead sponsor names by company — our grouping, not the registry's. It can be wrong or incomplete: an acquired company whose name never mentions its owner may be missing. Use “Something wrong?” under any name below to correct it.
Tell us about a missing company
Each name exactly as ClinicalTrials.gov lists it, and how it relates to Boston Scientific Corporation.
- Boston Scientific Corporation528 studiesSame company
Something wrong?
- Guidant Corporation17 studies →Acquired — became part of Boston Scientific Corporation, Apr 21, 2006 · source ↗
Something wrong?
- Symetis SA12 studies →Acquired — became part of Boston Scientific Corporation, May 16, 2017 · source ↗
Something wrong?
- Silk Road Medical10 studies →Acquired — became part of Boston Scientific Corporation, Sep 17, 2024 · source ↗
Something wrong?
- Farapulse, Inc.10 studies →Acquired — became part of Boston Scientific Corporation, Aug 6, 2021 · source ↗
Something wrong?
- Axonics, Inc.9 studies →Acquired — became part of Boston Scientific Corporation, Nov 15, 2024 · source ↗
Something wrong?
- Relievant Medsystems, Inc.7 studies →Acquired — became part of Boston Scientific Corporation, Nov 17, 2023 · source ↗
Something wrong?
- Baylis Medical Company4 studies →Acquired — became part of Boston Scientific Corporation, Feb 15, 2022 · source ↗
Something wrong?
- Claret Medical3 studies →Acquired — became part of Boston Scientific Corporation, 2018 · source ↗
Something wrong?
- Nalu Medical, Inc.3 studies →Acquired — became part of Boston Scientific Corporation, Jan 27, 2026 · source ↗
Something wrong?
- Boston Scientific Japan K.K.2 studies →Regional office
Something wrong?
- VertiFlex, Incorporated2 studies →Acquired — became part of Boston Scientific Corporation, Jun 11, 2019 · source ↗
Something wrong?
- EndoChoice Innovation Center, Ltd.2 studies →Acquired — became part of Boston Scientific Corporation, Nov 22, 2016 · source ↗
Something wrong?
- Preventice1 study →Acquired — became part of Boston Scientific Corporation, Mar 1, 2021 · source ↗
Something wrong?
- Asthmatx, Inc.1 study →Acquired — became part of Boston Scientific Corporation, Oct 2010 · source ↗
Something wrong?
- EndoChoice Inc.1 study →Acquired — became part of Boston Scientific Corporation, Nov 22, 2016 · source ↗
Something wrong?
Focus areas
Conditions Boston Scientific Corporation leads ten or more studies in, by study count. A broader condition is left out when almost all its studies are already in a narrower one listed here.
Studies
Recruiting first, then most recently updated. Showing 50 of 612. Browse all 612 →
- Drug-Eluting Registry: Real-World Treatment of Lesions in the Peripheral VasculatureRecruitingNCT04674969
- Randomized Study on Transoral Outlet Reduction and Lifestyle Changes for Weight Regain After Gastric BypassRecruitingNCT07015424Not applicable
- Radiofrequency (RF) Ablation Prospective Outcomes Study for Central Nervous System - RAPID for CNSRecruitingNCT06553625
- Vercise™ DBS Dystonia Prospective StudyRecruitingNCT02686125
- RELIEF - A Global Prospective Observational Post-Market Study to Evaluate Long-Term Effectiveness of Neurostimulation Therapy for PainRecruitingNCT01719055
- Boston Scientific Registry of Deep Brain Stimulation for Treatment of Essential Tremor (ET)RecruitingNCT04032470
- Intracept Minimally-invasive PROcedure for VErtebrogenic Back PainRecruitingNCT06827262
- Sacral Neuromodulation for Male Overactive Bladder (MOAB)RecruitingNCT06511141Not applicable
Sponsor listed in the registry: Axonics, Inc. · First submitted before Axonics, Inc. became part of Boston Scientific Corporation
- Axonics R20 Post-Market Clinical Follow-up (PMCF) Study for the Indication of Fecal IncontinenceRecruitingNCT07499258
Sponsor listed in the registry: Axonics, Inc. · First submitted after Axonics, Inc. became part of Boston Scientific Corporation
- Aquarius Pilot Study to Evaluate the New Axonics Trial SystemRecruitingNCT07335484Not applicable
Sponsor listed in the registry: Axonics, Inc. · First submitted after Axonics, Inc. became part of Boston Scientific Corporation
- Registry of Deep Brain Stimulation With the VERCISE™ System: Vercise DBS RegistryRecruitingNCT02071134
- Patient Retrospective Outcomes (PRO)RecruitingNCT01550575
- Deep Brain Stimulation (DBS) Retrospective Outcomes StudyRecruitingNCT03664609
- IT Matters: The Erectile Restoration RegistryEnrolling by invitationNCT04200937
- Managing Pain Using Optimized Sequences by Adjusting Parameters With Independent Current ControlRecruitingNCT07190807Not applicable
- The Evaluation of User Experience With FARAVIEW™ Technology of the OPAL HDx™ Mapping System When Used With the FARAWAVE NAV™ ULTRA Pulsed Field Ablation Catheter in the Treatment of Atrial FibrillationNot yet recruitingNCT07925359Not applicable
- Endo-SPONGE for Treatment of Anastomotic or Hartmann's Stump Leakages in Lower Pelvic AreaRecruitingNCT07035431Not applicable
- Impact of Endoscopic Sleeve Gastroplasty (ESG) in Obese Adults With Type 2 Diabetes (T2D)Not yet recruitingNCT07639684Not applicable
- Safety and Effectiveness of Orbera365™ Intragastric Balloon SystemRecruitingNCT07062094
- Safety and Effectiveness of Left Bundle Branch Area Pacing Versus Conventional Cardiac Resynchronization Therapy in Heart FailureRecruitingNCT07069738Not applicable
- BoStOn SCientific Rhythm MAnagemenT REgiStryRecruitingNCT04823663
- A Feasibility Study to Evaluate the Safety of the TheraSphere Glioblastoma (GBM) Device in Patients With Recurrent GBMRecruitingNCT05303467Phase 1
- Combined CM and STN Stimulation for Motor EpilepsyRecruitingNCT07458217Not applicable
- A Post Approval Study to Evaluate Safety and Effectiveness of Multicompartmental Dosimetry Planning.Not yet recruitingNCT07669727
- A Prospective, Multicenter, Single Arm Registry of ENROUTE NPS in Conjunction With Carotid WALLSTENT in Chinese PopulationNot yet recruitingNCT07458243
- OPTION-EMEA Clinical TrialRecruitingNCT07349121Not applicable
- Orbera365 Intragastric Balloon System (Abbreviated as'Orbera365')RecruitingNCT07195708Not applicable
- OverStitch NXT Endoscopic Suture SystemRecruitingNCT07276815Not applicable
- A Real-World Study of EkoSonic Endovascular System in Chinese Populations With Acute Pulmonary EmbolismRecruitingNCT06819865
- PVI Alone vs PVI and Linear Ablation for Persistent Atrial Fibrillation (PROMPT AF II)RecruitingNCT07106970Not applicable
- RHythmia mAPping and Signal acquisitiOn for Data analYsis (RHAPSODY)RecruitingNCT03053141
- Feasibility Study of the FARAFLEX Mapping and PFA SystemRecruitingNCT06510556Not applicable
- Evaluation of the FARAFLEX Mapping and Pulsed Field Ablation System in Subjects With Atrial FibrillationRecruitingNCT07575269Not applicable
- Evaluation of Novel Waveforms Delivered Using the FARAPULSE™ PFA SystemRecruitingNCT07444320Not applicable
- A Global Randomized Trial Evaluating the FARAFLEX™ Mapping and Pulsed Field Ablation System With Electrographic Flow Mapping in Patients Undergoing Repeat Ablation for Atrial FibrillationNot yet recruitingNCT07820930Not applicable
- A Study on the Acquisition of 2D ICE Images With the CHORUS IDx System in Subjects Undergoing an Ablation ProcedureRecruitingNCT07353710Not applicable
- Real-World Treatment of Extracranial Carotid Artery Disease With the ENROUTE™ Transcarotid Neuroprotection SystemRecruitingNCT07455747
- TheraSphere Japan Pre-Market StudyRecruitingNCT07377487Not applicable
- AGENT DCB STANCE: Safety and Effectiveness Study of AGENT Drug-Coated Balloon Compared to Standard of Care Percutaneous Coronary Intervention (PCI) Treatment for de Novo Coronary LesionsRecruitingNCT06959524Not applicable
- Study of Eso-SPONGE for Treating Leaks After Upper Gastrointestinal SurgeryNot yet recruitingNCT07711093Not applicable
- Elite AF IDE Trial (Elite AF)RecruitingNCT07287436Not applicable
- Fainting Detection And Early Warning In Syncope Evaluation Study (ARISE)RecruitingNCT07502599
- An Optimization Study Evaluating Safety and Efficacy of the Y-90 Glioblastoma (GBM) Device in Patients With Recurrent GBMNot yet recruitingNCT07867886Not applicable
- CHAMPION-AF Clinical TrialActive, not recruitingNCT04394546Not applicable
- LUX-Dx TRENDS Evaluates Diagnostics Sensors in Heart Failure Patients Receiving Boston Scientific's Investigational ICM System.CompletedNCT04790344Not applicable
- Ultrasound-facilitated, Catheter-directed, Thrombolysis in Intermediate-high Risk Pulmonary EmbolismCompletedNCT04790370Phase 4
- Clinical Study Of a Micro-Implantable Pulse Generator For The Treatment of Peripheral Neuropathic PainActive, not recruitingNCT05287373Not applicable
Sponsor listed in the registry: Nalu Medical, Inc. · First submitted before Nalu Medical, Inc. became part of Boston Scientific Corporation
- Safety, Performance, and Clinical Benefit of Pacing the Left Bundle Branch Area - Post-Market Clinical Follow-upActive, not recruitingNCT07209852
- F15 Recharge Free Axonics SNM System Clinical StudyActive, not recruitingNCT06186765Not applicable
Sponsor listed in the registry: Axonics, Inc. · First submitted before Axonics, Inc. became part of Boston Scientific Corporation
- A 5-year Superion™ IDS Clinical Outcomes Post-Approval Evaluation (SCOPE)Active, not recruitingNCT04192591Not applicable